Jennison Associates’s Auspex Pharmaceuticals ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
– Sell
-560,812
Closed -$29.4M – 789
2014
Q4
$29.4M Buy
560,812
+305,499
+120% +$8.97M 0.03% 401
2014
Q3
$6.55M Sell
255,313
-19,965
-7% -$425K 0.01% 497
2014
Q2
$6.13M Sell
275,278
-24,722
-8% -$541K 0.01% 494
2014
Q1
$9.23M Buy
+300,000
New +$8.06M 0.01% 491

Other funds holding ASPX

Jennison Associates's ASPX Position: Q1 2015 in Review

Jennison Associates sold out of Auspex Pharmaceuticals (ASPX) in Q1 2015, closing a stake of 560,812 shares — an estimated $29.4M sold.

Jennison Associates first reported a position in ASPX in Q1 2014 and held it in 4 quarters. The position peaked at $29.4M in Q4 2014. 138 funds tracked by Wall St. Rank hold ASPX as of Q1 2015.

  • Jennison Associates reported no remaining Auspex Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Jennison Associates sold 560,812 Auspex Pharmaceuticals shares in Q1 2015, an estimated $29.4M.
  • Jennison Associates first reported a position in Auspex Pharmaceuticals in Q1 2014 and held it in 4 quarters.
  • Jennison Associates's Auspex Pharmaceuticals position peaked at $29.4M in Q4 2014.
  • 138 funds tracked by Wall St. Rank held Auspex Pharmaceuticals as of Q1 2015.

Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.